In a significant stride towards innovation, UK-based Mable Therapy, a trailblazer in speech therapy, has ignited a transformative journey. The company secured an impressive infusion of £3.1 million in funding, accompanied by strategic leadership appointments that promise to reshape the realm of children's speech and language therapy.
Beneath the surface of this groundbreaking evolution lies the partnership with Gresham House Ventures, lending a resounding endorsement to Mable Therapy's vision. A new era dawns with the appointment of Oli White, who brings a trail of accomplishments from his role as COO at Doc Adobe, stepping into the coveted CEO position. The ensemble grows stronger as Andrea Carr assumes the mantle of an independent chair, infusing fresh perspectives and strategic guidance.
Established in 2015 by the dynamic duo of Martha Currie and Elliot Agró, Mable Therapy emerges as a beacon of hope for those seeking speech and language therapy services. With an expansive network of therapists spanning the nation, Mable Therapy extends a lifeline to patients, facilitating 1-2-1 sessions catering to children's speech and language therapy and counseling requirements.
Fueling this audacious pursuit, the freshly acquired funds usher forth a bold vision—an intra-therapy app meticulously curated to empower and engage children beyond scheduled sessions' confines. Coupled with this, Mable Therapy sets its sights on equipping educators with powerful school screening tools, facilitating a nuanced evaluation of student's mental health and speech and language needs.
Oli White's visionary perspective echoes, "This investment unfurls the wings of our aspirations, amplifying our impact across sectors where our technology has already left an indelible mark. Guided by Gresham House Ventures' unparalleled expertise, Mable Therapy is primed to embark upon an accelerated trajectory of growth."
Benjamin Faulkner, associate director at Gresham House Ventures, lends his voice to the chorus of optimism. "Mable's technology wields the power to transform the lives of children during their formative stages. The horizon brims with potential as Mable Therapy's offerings hold the key to unlocking efficiencies for public service providers within the expansive landscape of education and health sectors."
This triumphant evolution is a testament to the fusion of clinical expertise and technological prowess. Mable Therapy's unwavering commitment to revolutionizing vital support across the UK resonates with fervor, casting a radiant light on the journey ahead.
